NCT01355055
Unknown
Not Applicable
Influences of Catheter-based Renal Denervation on Central Sympathetic Nervous System Regulation in Refractory Hypertension
ConditionsHypertension
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Hannover Medical School
- Enrollment
- 26
- Locations
- 1
- Last Updated
- 14 years ago
Overview
Brief Summary
Primary hypothesis:
Catheter-based renal denervation reduces central sympathetic activation in patients with refractory hypertension.
Secondary hypotheses:
- The magnitude of the individual depressor response after catheter-based renal denervation depends on the extent of sympathoinhibition.
- Both, the reduction in arterial pressure and in central sympathetic activation are sustained over time up to 24±3 months after catheter-based renal denervation.
- Catheter-based renal denervation resets the sympathetic baroreflex to lower blood pressure values.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Refractory hypertension (as defined by the WHO: poorly controlled hypertension (\>140/90 mmHg) despite adequate doses of at least three antihypertensive drugs including a diuretic)
- •Men or women aged \>18 years
- •Intact peroneal nerve
- •Written informed consent
Exclusion Criteria
- •Diseases, dysfunctions, or medications (such as NET inhibitors) that exclude a participation in the study according to the investigator.
- •Legal incompetence or circumstances that interfere with the patient´s ability to fully understand scope, relevance, and/or consequences of participation in this study.
- •People in custody
- •hypersensitivity to clonidine, phenylephrine, or nitroprusside-sodium
- •sick sinus syndrome, second or third degree AV block, bradycardia \< 50 bpm (contraindication for clonidine)
- •endogenous depression (contraindication for clonidine)
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial FibrillationAtrial FibrillationHypertensionNCT01873352Meshalkin Research Institute of Pathology of Circulation302
Unknown
Not Applicable
Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI EvaluationUncontrolled HypertensionNCT02164435University of Adelaide20
Terminated
Phase 4
Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Trial From RENEWAL RDN Registry)Resistant HypertensionNCT01918111Yonsei University16
Completed
Not Applicable
Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney DiseaseHypertensionChronic Kidney DiseaseNCT02863510Heart of England NHS Trust10
Completed
Not Applicable
Effect of renal sympathetic denervation on renal and overall sympathetic output in patients with therapy resistant hypertensioTherapy resistant hypertensionrenal sympathetic denervation1001842410057166NL-OMON37991Academisch Medisch Centrum30